ArticleMedical hypotheses2022

Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension.

Jong Han LeePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.